Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Sunshine Biopharma Inc SBFM

Healthcare Biotechnology

Sunshine Biopharma, Inc. is a Canada-based pharmaceutical company. The Company offers and researches life-saving medicines in a variety of therapeutic areas, including oncology and antivirals. The Company has 27 additional generic prescription drugs. In addition, the Company is engaged in the development of various proprietary drugs, including Adva-27a, K1.1 mRNA and SBFM-PL4. Adva-27a is a... see more

Add To Watchlist

Recent & Breaking News (NDAQ:SBFM)

Sunshine Biopharma, Inc. Announces Pricing of $8.0 Million Private Placement Priced At-the-Market

GlobeNewswire March 10, 2022

Sunshine Biopharma Expands Anti-Coronavirus Drug Development Program By Signing A Collaboration Agreement With The University Of Arizona

GlobeNewswire February 25, 2022

Aegis Capital Corp. acted as Sole Bookrunner on an Uplist of an $8 Million Underwritten Public Offering for Sunshine Biopharma Inc. (NASDAQ: SBFM; SBFMW)

Accesswire February 17, 2022

Sunshine Biopharma, Inc. Announces Closing of $8 Million Public Offering and Uplisting to the Nasdaq Capital Market

GlobeNewswire February 17, 2022

Sunshine Biopharma, Inc. Announces Pricing of $8 Million Public Offering and Uplisting to the Nasdaq Capital Market

GlobeNewswire February 15, 2022

Sunshine Biopharma Announces $1,361,000 in Debt Reduction

GlobeNewswire December 22, 2021

Sunshine Biopharma Expands Board of Directors

GlobeNewswire November 3, 2021

Sunshine Biopharma Files a Patent Application Covering mRNA Molecules for Treatment of Neurodegenerative Diseases

GlobeNewswire October 6, 2021

Sunshine Biopharma Receives Health Canada Approval for Essential 9TM, The Company's First Over The Counter Essential Micronutrient

Accesswire December 17, 2018

Sunshine Biopharma Signs an Agreement with Crocus Laboratories for Manufacturing of Adva-27a Anticancer Drug

Accesswire December 12, 2018

Sunshine Biopharma Announces $10 Million Equity Financing

Accesswire September 14, 2018

Sunshine Biopharma Signs A Service Agreement With Utah Based Quintessential Biosciences Inc.

Accesswire August 16, 2018

Sunshine Biopharma Launches Microbiology Testing Service

Accesswire June 18, 2018

Sunshine Biopharma Announces Extension of The Term of Its Brokered Up To $10 Million Private Placement Financing

Accesswire May 10, 2018

Sunshine Biopharma Completes the Acquisition of Atlas Pharma

Accesswire January 4, 2018

Sunshine Biopharma Announces the Terms of Its Brokered up to $10 Million in Private Placement Financing

Accesswire September 19, 2017

Sunshine Biopharma Enters into an Investment Banking Agreement with Jitney Trade to Raise up to $10 Million for Clinical Trials of Adva-27a Anticancer Drug

Accesswire September 5, 2017

Sunshine Biopharma Releases Results of Independent Valuation

Accesswire June 26, 2017

Sunshine Biopharma Files an Application with Health Canada for a Drug Establishment License

Accesswire June 19, 2017

Sunshine Biopharma Currently Reviewing Twenty-Three Additional Generic Products for In-Licensing

Accesswire January 11, 2017